quantisnow
FeedTopReportsPricing
⌘K
Live feed
09:56:56·849d
NEWSRelease
Baosheng Media Group Holdings Limited logo
Coherus Oncology Inc. logo
Cingulate Inc. logo
+4

US Stocks Edge Higher; Coherus Reports FDA Approval Of UDENYCA ONBODY

BAOS· Baosheng Media Group Holdings LimitedCHRS· Coherus Oncology Inc.CING· Cingulate Inc.FWBI· First Wave BioPharma Inc.HALL· Hallmark Financial Services Inc.IOVA· Iovance Biotherapeutics Inc.
Real EstateHealth CareFinance
Original source

Companies

  • BAOS
    Baosheng Media Group Holdings Limited
    Real Estate
  • CHRS
    Coherus Oncology Inc.
    Health Care
  • CING
    Cingulate Inc.
    Health Care
  • FWBI
    First Wave BioPharma Inc.
    Health Care
  • HALL
    Hallmark Financial Services Inc.
    Finance
  • IOVA
    Iovance Biotherapeutics Inc.
    Health Care
  • ROI
    RiskOn International Inc.
    Energy

Recent analyst ratings

  • Feb 25IOVAUpdateCitizens$5.00
  • Jan 23CHRSUpdateOppenheimer$10.00
  • Sep 4CHRSUpdateMaxim Group-
  • Jul 15IOVAUpdateGoldman$1.00
  • May 16IOVAUpdateUBS$2.00
  • May 12IOVAUpdateTruist-

Related

  • SEC4d
    SEC Form DEF 14A filed by Coherus Oncology Inc.
  • PR6d
    Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
  • SEC6d
    SEC Form PRE 14A filed by Iovance Biotherapeutics Inc.
  • SEC9d
    SEC Form S-3 filed by Cingulate Inc.
  • SEC9d
    SEC Form DEFA14A filed by Coherus Oncology Inc.
  • SEC14d
    SEC Form PRE 14A filed by Coherus Oncology Inc.
  • SEC15d
    SEC Form 6-K filed by Baosheng Media Group Holdings Limited
  • SEC21d
    Cingulate Inc. filed SEC Form 8-K: Leadership Update
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022